Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.

Authors	Achille Marino, Francesco Orsini, Francesca Pregnolato, Rolando Cimaz
Journal	The Journal of rheumatology (J Rheumatol) Vol. 49 Issue 6 Pg. 654-656 (06 2022) ISSN: 0315-162X [Print] Canada
PMID	35293329 (Publication Type: Journal Article)
Chemical References	Antirheumatic Agents Tumor Necrosis Factor-alpha Rituximab
Topics	Antirheumatic Agents (therapeutic use) Arthritis, Juvenile (drug therapy) Humans Pilot Projects Rituximab (therapeutic use) Tumor Necrosis Factor-alpha

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!